COIOSDeep risk insights through multi-disciplinary research across the globe
aerial view of buildings
Item refines Peer-reviewed Added

Breast cancer survival by stage across Europe after harmonising registry TNM data

Ten-year relative survival of European women with breast cancer was 97% at stage I and 10% at stage IV.

Researchers studied 714 864 women with breast cancer diagnosed in 2001–2013, from 23 population-based registries in 14 European countries. Stage from three TNM editions was converted to seventh-edition stages I–IV, and survival used 2010–2014 period analysis. Age-adjusted 10-year relative survival fell from 97% in stage I to 82%, 51% and 10% in stages II–IV. Stage IV survival ranged from 3% in Northern Ireland to 22% in Switzerland, while stage I varied little. Limitations include 59 registries dropped for missing stage, low coverage in Italy and Spain, and no treatment data. Converting between TNM editions may also have moved some cases between stages, known as stage migration.

Why it is interesting: Earlier conversion algorithms merged stages II and III into one regional group. Here, a four-level stage shows gaps between countries mainly in advanced disease, while stage I survival is close to uniform.

Source
ESMO Real World Data and Digital Oncology, 30 October 2026
Paper
Standardisation of stage information collected by European population-based cancer registries: an application to breast cancer survival
Authors
Rossi S, Cerza F, Bennett D, Innos K, Henau K, Demuru E et al.
DOI
10.1016/j.esmorw.2026.100794
Full text
Open copy (open-access copy, PubMed Central)
Type
Peer-reviewed article
Design
Population-based registry analysis, 714,864 female breast cancer cases diagnosed 2001-2013, 23 registries in 14 European countries (EUROCARE-6), period analysis of 10-year relative and conditional survival for 2010-2014
Verdict
Refines prior evidence
Driver
Cancer
Free full text
Free to read at the publisher

Other drivers in Health today